CGEM
USDCullinan Therapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$7.800
Máximo
$7.800
Mínimo
$7.360
Volumen
0.61M
Fundamentos de la Empresa
Capitalización de Mercado
437.2M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.89M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting
CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ~30% CRc rate observed at clinically
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
CLN-978 led to rapid and deep B cell depletion in vitro and in vivo in multiple autoimmune diseases CAMBRIDGE, Mass., Oct. 25, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (NASDAQ:CGEM), a clinical-stage
Acciones Relacionadas
PEG
Public Service Enterprise Group Incorporated
WISA
WiSA Technologies Inc.
CSLM
CSLM Acquisition Corp. Ordinary Share
GAB
Gabelli Equity Trust Inc. (The)
BTOG
Bit Origin Limited Ordinary Shares
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.